In breast cancer, nestin, an extracellular matrix (ECM) intermediate filament protein, inhibits FZD1 expression and thereby β-catenin signaling, resulting the halt of proliferation and invasion of breast tissues by decreasing the expression of matrix metallopeptidase92. This evidence concerns the gene FZD1 and breast cancer.